financetom
Business
financetom
/
Business
/
Red Rock Resorts Q2 revenue beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Red Rock Resorts Q2 revenue beats estimates
Jul 29, 2025 1:29 PM

Overview

* Red Rock Resorts ( RRR ) Q2 revenue rises 8.2% yr/yr, beating analyst expectations

* Adjusted EBITDA for Q2 beats consensus, rising 13.7% yr/yr

* Net income for Q2 increases 55.1% yr/yr to $108.3 mln

Result Drivers

* LAS VEGAS OPERATIONS - Net revenues from Las Vegas operations increased by 6.2%, contributing significantly to overall revenue growth

* NATIVE AMERICAN FEES - $10 mln revenue catch-up from Native American management activities boosted results

* DEVELOPMENT GAINS - Gain on Native American development contributed positively to net income

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $526.27 $485.60

Revenue mln mln (11

Analysts

)

Q2 EPS $0.96

Q2 Net $108.25

Income mln

Q2 Beat $229.40 $195.70

Adjusted mln mln (11

EBITDA Analysts

)

Q2 EBIT $168.03

mln

Q2 $124.18

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the casinos & gaming peer group is "buy"

* Wall Street's median 12-month price target for Red Rock Resorts Inc ( RRR ) is $58.00, about 5.7% above its July 28 closing price of $54.72

* The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 23 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Msci Insider Sold Shares Worth $2,841,787, According to a Recent SEC Filing
Msci Insider Sold Shares Worth $2,841,787, According to a Recent SEC Filing
Mar 7, 2025
04:11 PM EST, 03/07/2025 (MT Newswires) -- C. D. Baer Pettit, Director, President & COO, on March 05, 2025, sold 5,000 shares in Msci ( MSCI ) for $2,841,787. Following the Form 4 filing with the SEC, Pettit has control over a total of 299,787 common shares of the company, with 299,787 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1408198/000140819825000085/xslF345X05/wk-form4_1741381291.xml ...
Castellum Insider Sold Shares Worth $717,450, According to a Recent SEC Filing
Castellum Insider Sold Shares Worth $717,450, According to a Recent SEC Filing
Mar 7, 2025
04:09 PM EST, 03/07/2025 (MT Newswires) -- Jay O Wright, 10% Owner, Director, General Counsel, Secretary, and Executive Vice President, Strategy, on March 05, 2025, sold 500,000 shares in Castellum (CTM) for $717,450. Following the Form 4 filing with the SEC, Wright has control over a total of 9,523,673 common shares of the company, with 9,523,673 shares held directly. SEC...
Marsh & Mclennan Companies Insider Sold Shares Worth $2,545,206, According to a Recent SEC Filing
Marsh & Mclennan Companies Insider Sold Shares Worth $2,545,206, According to a Recent SEC Filing
Mar 7, 2025
04:10 PM EST, 03/07/2025 (MT Newswires) -- John Jude Jones, Chief Marketing Officer, on March 06, 2025, sold 10,824 shares in Marsh & Mclennan Companies ( MMC ) for $2,545,206. Following the Form 4 filing with the SEC, Jones has control over a total of 9,723 common shares of the company, with 7,978 shares held directly and 1,745 controlled indirectly....
Bayer told analysts of cash call plan a day before official statement
Bayer told analysts of cash call plan a day before official statement
Mar 7, 2025
FRANKFURT (Reuters) -Bayer told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, which weighed heavily on the stock, analysts' notes seen by Reuters showed. The healthcare and agriculture group said in a statement on Friday it would seek shareholder approval at its annual meeting on April 25 potentially...
Copyright 2023-2026 - www.financetom.com All Rights Reserved